Navigation Links
Hope for the overweight
Date:7/31/2014

White, brown and beige adipocytes, or fat cells, are inherently different. Each of these cell types has different functions and each plays its own role in metabolism. In the human body, white adipose tissue is by far the most prevalent. Its primary function is energy storage. On the other hand, brown adipocytes utilize available energy to generate heat but are only found in a few places in the adult human body. Beige adipocytes, which represent a special type of brown adipocytes, appear mixed with brown adipocytes in human brown adipose tissue or develop within the white adipose tissue, particularly under the influence of cold in rodents.

A team of researchers headed by Dr. Siegfried Ussar from the Institute for Diabetes and Obesity (IDO) at the Helmholtz Diabetes Center/ Helmholtz Zentrum Mnchen, partner of the German Center for Diabetes Research (DZD), and Professor C. Ronald Kahn from the Joslin Diabetes Center and Harvard Medical School has now succeeded in very specifically distinguishing the various adipocytes on the basis of their surface proteins. This is raising hope for a new method to treat those suffering from obesity and diabetes.

The good and the bad side of fat

Rapidly growing rates of obesity result in increasing rates of type 2 diabetes and other components of the metabolic syndrome. To ameliorate the consequences of excessive caloric intake and storage, modern medicine is seeking new ways to enhance energy expenditure to reduce body weight. "Because of its function as the body's thermal power station, brown adipose tissue has the ability to burn large quantities of energy that otherwise would be stored in white adipose tissue as fat," says first author Siegfried Ussar. For this reason, activation of brown adipose tissue using drugs offers an attractive approach to treat obesity and the illnesses that result from it, such as type 2 diabetes.

The amount of brown adipose tissue varies greatly from indivi
'/>"/>

Contact: Dr. Siegfried Ussar
siegfried.ussar@helmholtz-muenchen.de
49-893-187-2047
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Overweight? New research explains how proper sleep is important for healthy weight
2. Omega-3 lowers inflammation in overweight older adults
3. Overweight? Theres a vaccine for that
4. Infants of overweight mothers grow more slowly
5. Antibiotic use in infants before 6 months associated with being overweight in childhood
6. Older overweight children consume fewer calories than their healthy weight peers
7. Parents talking to their teens about being overweight
8. Overweight pregnant women not getting proper weight-gain advice
9. Being overweight linked to higher risk of gum disease
10. Rare pregnancy condition programs babies to become overweight in later life
11. Genetic mutation may play key role in risk of lethal prostate cancer in overweight patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2015)... PRINCETON, N.J. , June 25, 2015  TAKE ... awarded a patent by the United States Patent and ... Data Standardization". This process leverages TAKE Solutions, Clinical Accelerators ... by over 50% (when compared to standardization without the ... At the heart ...
(Date:6/24/2015)... 2015 Research and ... the "Huawei Ascend Mate 7 Fingerprint Sensor ... offering. Huawei,s technological choice for the ... than Apple,s and Samsung,s one. The Ascend Mate ... Fingerprint Cards, a main actor in capacitive sensing ...
(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... In a new study this week, Rice University scientists bring ... how the processes of natural selection and evolution influence the ... available online from Physical Review Letters . It builds ... genetics in the past decade -- the revelation that bacteria ...
... Society for Medical Oncology (ESMO) honors three eminent cancer specialists ... awards will be presented to Hilary Calvert, Alberto Costa and ... from 8-12 October in Milan, Italy. Dr Alberto Costa ... key role in the development of international guidelines for breast ...
... Chen and his colleagues will use next-generation DNA sequencing technologies ... largest source of natural and renewable fiber in the world, ... (NSF). One of the goals of the project is ... multibillion-dollar crop in the U.S. and one of the country,s ...
Cached Biology News:Rice study examines how bacteria acquire immunity 2Rice study examines how bacteria acquire immunity 3Top cancer specialists receive ESMO awards 2Top cancer specialists receive ESMO awards 3Top cancer specialists receive ESMO awards 4Improving cotton the goal of $3.8 million grant to University of Texas at Austin plant geneticist 2
(Date:7/2/2015)... ... 2015 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), a ... the acquisition of Turner Medical, Inc ., thus becoming a global leader ... Spine Industry. The acquisition of Turner Medical ideally supplements In’Tech Medical’s product offering, ...
(Date:7/1/2015)... ... ... The next-generation sequencing (NGS) clinical market is poised for huge growth as it prepares ... in its new report that the market drivers of this vibrant industry include increased ... diagnostics as part of a molecular diagnostics trend. , The global market is forecast ...
(Date:7/1/2015)... 1, 2015 Isagenix International, a leading global ... Gold, three Silver, and three Bronze Stevie® Awards at ... Chicago this month.The American ... awards program in the U.S. "Winning ... in developing leaders, cultivating talent, creating a unified team, ...
(Date:7/1/2015)... ... July 01, 2015 , ... NEMA 4 (IP66) Medical Joysticks ... Medical Joysticks have an impermeable molecular barrier protection against bio-hazardous agents. Original ... will increase healthcare worker safety and reduce financial costs. , CTI Electronics announces ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... Sinovac Biotech Ltd. (Amex:,SVA), a vaccine-focused biotech company ... President and CEO, is scheduled to present at ... at Grant Hyatt Beijing Hotel in Beijing, China. ... 1:35 p.m., About Sinovac, Sinovac Biotech ...
... Sept. 1 ,Boston Scientific Corporation (NYSE: ... landmark SYNTAX trial comparing percutaneous coronary intervention,(PCI) ... to contemporary coronary artery bypass graft (CABG) ... differences,between PCI and CABG in rates of ...
... in title Coronary Artery Disease, ... ivabradine in reduction of cardiovascular ... artery ... dysfunction, ESC Hotline 31st August 2008, ...
Cached Biology Technology:Sinovac to Present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 3Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 4Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 5With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients 2With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients 3